Dr Azizun Nahar, Associate Professor of Microbiology, Bangladesh Medical College (BMC), Dhaka, Bangladesh; E-mail:
Mymensingh Med J. 2024 Apr;33(2):486-491.
In cardiovascular homeostasis thyroid hormone plays an important role. We planned to study the changes in thyroid hormone profile in acute coronary syndrome patients admitted in the coronary care unit and compare them between two groups: unstable angina/non-ST elevated Myocardial infarction (UA/NSTEMI) and ST elevated Myocardial infarction (STEMI). This study was a hospital based descriptive cross sectional study which was conducted from 01 March 2018 to 01 February 2019 in Coronary Care Unit of Bangladesh Medical College Hospital and laboratory tests were done in Microbiology Department of Bangladesh Medical College, Dhaka, Bangladesh. Eighty three cases of acute coronary syndromes were taken for the study. Troponin-I was measured as cardiac marker, Electrocardiogram, Complete blood count, blood glucose level, Blood urea, serum creatinine, serum electrolytes, Fasting lipid profile, Thyroid profile, Echocardiography 2D were done. Most of the respondents were distributed in age group 46-60 years where 34(64.15%) male and 19(35.85%) female. Out of 83 Acute Coronary Syndrome (ACS) patients, 27(32.53%) hypertensive, 22(26.50%) diabetic and 16(19.27%) were Chronic kidney disease (CKD). Abnormal lipid profile was present in 30(43.47%) patients. Among total 52 male and 31 female 9(17.30%) male and 6(19.35%) female had abnormal thyroid function. We further elaborated abnormal thyroid function tests in STEMI group and UA/Non STEMI group of ACS patients. We found 10 patients in STEMI group and 5 patients in UA/Non STEMI group with abnormal thyroid function 29.41% and 10.20% respectively which was not statistically significant (p=0.025). This study depicts abnormality in thyroid hormone profile in 18.07% patients of ACS. Abnormal thyroid function increases risk of coronary artery disease. TSH level of ACS patients on hospital admission could be helpful to evaluate further prognosis of the disease.
在心血管稳态中,甲状腺激素起着重要作用。我们计划研究急性冠状动脉综合征患者在冠心病监护病房中甲状腺激素谱的变化,并将其在不稳定型心绞痛/非 ST 段抬高型心肌梗死(UA/NSTEMI)和 ST 段抬高型心肌梗死(STEMI)两组之间进行比较。这项研究是一项基于医院的描述性横断面研究,于 2018 年 3 月 1 日至 2019 年 2 月 1 日在孟加拉国医学院附属医院冠心病监护病房进行,实验室测试在孟加拉国达卡的孟加拉国医学院微生物学系进行。研究纳入了 83 例急性冠状动脉综合征患者。肌钙蛋白 I 作为心脏标志物进行测量,同时进行心电图、全血细胞计数、血糖水平、血尿素、血清肌酐、血清电解质、空腹血脂谱、甲状腺谱、二维超声心动图检查。大多数受访者分布在 46-60 岁年龄组,其中 34 名(64.15%)为男性,19 名(35.85%)为女性。在 83 例急性冠状动脉综合征(ACS)患者中,27 例(32.53%)患有高血压,22 例(26.50%)患有糖尿病,16 例(19.27%)患有慢性肾病(CKD)。30 例(43.47%)患者存在血脂异常。在总共 52 名男性和 31 名女性中,9 名(17.30%)男性和 6 名(19.35%)女性的甲状腺功能异常。我们进一步阐述了 ACS 患者中 STEMI 组和 UA/NSTEMI 组异常甲状腺功能的情况。我们发现 STEMI 组有 10 例患者,UA/NSTEMI 组有 5 例患者甲状腺功能异常,分别为 29.41%和 10.20%,差异无统计学意义(p=0.025)。这项研究表明,ACS 患者中有 18.07%存在甲状腺激素谱异常。异常甲状腺功能会增加患冠状动脉疾病的风险。ACS 患者入院时的 TSH 水平有助于评估疾病的进一步预后。